This issue of Phlebology marks the last in which I shall act as Editor in Chief. I commenced my association with this journal with volume 7 so this will be the end of an eleven year period of duty. During this time I have tried to improve the scientific excellence of the journal in order to raise the profile ofthe clinical practice ofphlebology in the world scientific literature. I hope that you will agree that I have made some progress in preparing Phlebology for the rigours of the 21st century. As a consequence of the improvements this journal is now listed in Current Contents as well as Embase. However, Index Medicus has remained resistant to our overtures and to my dismay no phlebological journal in the world is currently listed in this database. This is regrettable and compounds the problem of producing a successful journal in this area. I wish my capable successor, Alun Davies, every success in pursuing the success of this journal.
During the past 11 years many innovations have been covered in the pages of Phlebology. The return of saphenous vein stripping which occurred about 10-15 years ago, brought about the need for improved methods of achieving vein stripping with minimal trauma to the patient. Andreas Oesch published his method of stripping involving use of a new device, the pin-stripper. This has gained widespread popularity and is in common use throughout the world.
In the early nineties there was considerable interest in angioscopy in the management of vascular disorders. Some papers have been published in Phlebology on this subject but it is not a technique which has gained widespread popularity and appears to be infrequently used in venous disease. Some applications include monitoring of the repair of deep vein valves as well as a mechanism for controlling ultrasound guided sclerotherapy.
A number of papers have described methods of repairing deep vein valves in the management of the PHLEBOLOGY more severe stages of venous disease. In addition, enthusiasts of the preservation of the long saphenous vein have reported a techniques for restoring the sapheno-femoral valve to health. These have included Rod Lane's Venocuff and other methods of plication of the sapheno-femoral junction. None of these methods appears to be in widespread use at present. We have also covered the French CHIVA method of partial saphenous vein preservation. I understand that this is now confined to use by a small number of French experts but is enjoying a renaissance in Italy. We have also included mention of the 'V-clip' intended to restore competence to saphenous vein valves. Again, this technique has not received wide acceptance.
Despite the efforts made to develop methods of repairing incompetent saphenous trunks, none has succeeded and perhaps we have encountered a biological limitation of this philosophy. Venous valves in varicose veins cannot reliably be restored to heath. Instead many surgeons are turning to more sophisticated methods of destroying saphenous veins! These include use of radio frequency diathermy catheters and laser fibres to heat veins to destruction. Both methods are technologically complex and fail to deal with superficial varices which have to be removed by phlebectomy or by sclerotherapy. In a recent issues of Phlebology, Cabrera at al. and Cavezzi et al have described the advantages of ultrasound guided foam sclerotherapy. Ultrasound guided sclerotherapy has been widely used in some countries for about 15 years but conventional sclerosing drugs appear to be of limited efficacy when employed to treat saphenous trunks. Foam sclerosants are much more effective and may offer the prospect of permanent saphenous trunk occlusion from a single foam injection. However, in common with the RF diathermy and laser techniques, the sapheno-femoral and sapheno-popliteal junctions are not occluded by the new treatments. Many 88 surgeons would say that this is a recipe for recurrence. Enthusiasts of foam argue that even is more varices do appear, it if a minor procedure to obliterate them with further foam injections. Sadly lacking in this field are controlled trials comparing the new techniques with surgery, and even clinical series with sufficient followup to be sure of the long term outcome are missing from the literature at present. Over the years since I have edited this journal, duplex ultrasonography has now become the standard method of investigating venous diseases. This method offers the prospect of predicting the outcome from these new treatments even before long term clinical follow-up can be completed. John Hobbs [1] had to wait 10 years to demonstrate that conventional sclerotherapy produced a poorer result than surgical treatment for varicose veins resulting from truncal saphenous incompetence. The recurrence of varices is probably preceded by the re-establishment of venous reflux in saphenous trunks, an event which can easily be detected by duplex ultrasonography. Future studies will use this method to predict the likely development of recurrence, allowing modifications of the techniques to be made without allowing 10 years to elapse before the eventual outcome is established.
Although the new methods of treating varicose veins currently all have some limitations of applicability and efficacy, careful development of these methods will eventually reduce the amount of surgery that we perform. The latter has remained little changed since the time of Babcock and Keller nearly 100 years ago. It is surely time that more sophisticated and less invasive methods become commonplace.
One area in which little progress has been made in treatment is the management of leg ulcers. These continue to be a substantial burden on healthcare systems, and yet I frequently recall that Hippocrates used bandaging for leg ulcers 2500 years ago. The most effective non-surgical treatment today remains the use of compression bandaging. Of course, we know much more of the mechanisms involved in the development of leg ulcers but so far this has not led to any great advance in treatment. I had hoped that possible candidate drugs may have arise from this research, but clinical trials have shown relatively modest effects of all those used so far. I think that eventually we will rely more considerably on drugs in the healing and maintenance of healing of leg ulcers. Much more work will be required in order to achieve this. Of course, many new dressings and topical Philip Coleridge Smith applications have been developed which greatly facilitiate the management of leg ulcers. However, none has been shown convincingly to speed ulcer healing. Surgical intervention is used on a very limited scale in the management of leg ulceration due to deep vein incompetence. No major advance has been achieved over the last decade in this field and deep vein reconstruction using a number of different techniques is confined to a small number of experts scattered around the world. Few patients appear to have been treated in this way compared to the huge number with deep vein incompetence who might benefit from repairs to their deep vein valves. It seems likely that surgical interventions for deep vein incompetence will contribute on only a very small scale in the management of venous disease. Interventional radiology has seen huge advances in the last lO years but has yet to make a significant impact on venous disease. Certainly patients with iliac vein occlusion may benefit from dilation and stenting of their stenotic or occluded iliac veins, but again this remains a treatment performed in a limited number of centres. A number of attempts have been made to devise valves which can be introduced through a catheter and inserted in an incompetent deep vein. However, these currently remain under development largely due to thrombotic problems with many of the devices so far tested. Assuming that these can be overcome by selection of suitable materials, then trans luminal delivery of new valves may be a possible means of reestablishing competence in patients with deep vein incompetence.
Phlebology remains a speciality in which not enough science has been applied to the evaluation of possible new treatments in many different areas, considering the frequency with which these diseases occur. Patients now demand more and better treatments and in part this has encouraged enthusiastic surgeons and physicians into more detailed research and renewed efforts to improve on existing methods of management. I hope that the new Editor in Chief of Phlebology will have the opportunity to publish more success stories during his term of office.
